Experienced investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in corporate strategy, capital raising and operational scaling. Carrie Miller brings cross-functional experience from senior roles in private equity and venture-backed startups, advising boards on go-to-market and M&A. Active in sourcing early growth opportunities, structuring rounds and supporting management teams on commercialization and financial governance. Regular commentator in investor forums and known for pragmatic, growth-oriented value creation.
Experienced investor and operating executive focused on growth-stage technology and healthcare companies, with expertise in corporate strategy, capital raising and operational scaling. Carrie Miller brings cross-functional experience from senior roles in private equity and venture-backed startups, advising boards on go-to-market and M&A. Active in sourcing early growth opportunities, structuring rounds and supporting management teams on commercialization and financial governance. Regular commentator in investor forums and known for pragmatic, growth-oriented value creation.
Prioritizes growth-stage technology and healthcare investments where operational leverage and repeatable go-to-market can accelerate scale. Emphasizes rigorous commercial due diligence, disciplined capital allocation across tranche-based rounds, and active board-level partnership to drive revenue, margin expansion and M&A optionality. Balances conviction bets with portfolio diversification, favors companies with defensible distribution channels and strong metrics, and deploys pragmatic governance and milestone-driven capital to de-risk execution.
Prioritizes growth-stage technology and healthcare investments where operational leverage and repeatable go-to-market can accelerate scale. Emphasizes rigorous commercial due diligence, disciplined capital allocation across tranche-based rounds, and active board-level partnership to drive revenue, margin expansion and M&A optionality. Balances conviction bets with portfolio diversification, favors companies with defensible distribution channels and strong metrics, and deploys pragmatic governance and milestone-driven capital to de-risk execution.
| Trades 392 | Longs Won 327/392 83% | Profit Factor 146.83 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.53M |
| Average Win $373,361.46 | Best Trade (Aug 17) $17.14M | Sharpe Ratio -10.26 |
| Average Loss -$12,792.04 | Worst Trade (Mar 30) -$87,550 | Z-Score 18.15 (100%) |
| Commissions $0 | Avg. Trade Length 1y 7m 1w 3d | Expectancy $309,330.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.02% |
| Consecutive Losing Trades | 23,256 | 20,930 | 18,605 | 16,279 | 13,953 | 11,628 | 9,302 | 6,977 | 4,651 | 2,326 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 2,708 | $630,972.68 | $836,528.28 | - | $205,555.6 | 32.58% | -7.354% |
AMZN Amazon.com Inc | 20,735 | $4.32M | $5.63M | - | $1.31M | 30.4% | +15.321% |
AVDE Avantis International Equity ETF | 250,006 | $13.76M | $22.8M | - | $9.04M | 65.72% | -0.458% |
AVDV Avantis International Small Cap Value ETF | 2,211 | $220,888.09 | $231,359.04 | - | $10,470.95 | 4.74% | -0.476% |
AVEM Avantis Emerging Markets Equity ETF | 80,537 | $4.22M | $7.21M | - | $2.98M | 70.67% | +0.101% |
AVSD Avantis Responsible International Equity ETF | 24,959 | $1.33M | $2.03M | - | $693,772.73 | 52.07% | -0.616% |
AVSE Avantis Responsible Emerging Markets Equity ETF | 8,552 | $410,403.09 | $641,896.01 | - | $231,492.92 | 56.41% | +0.101% |
AVSU Avantis Responsible U.S. Equity ETF | 31,912 | $1.77M | $2.79M | - | $1.02M | 57.58% | +0.437% |
AVUS Avantis U.S. Equity ETF | 205,672 | $14.5M | $26.24M | - | $11.75M | 81.05% | +0.567% |
AVUV Avantis U.S. Small Cap Value ETF | 3,929 | $382,606.69 | $492,225.12 | - | $109,618.43 | 28.65% | +0.032% |
BLND Blend Labs Inc. | 10,932 | $46,023.74 | $19,458.96 | - | -$26,564.78 | -57.72% | +1.714% |
BND Vanguard Total Bond Market Index Fund | 202,849 | $14.86M | $14.65M | - | -$208,456.09 | -1.4% | -0.262% |
BNDX Vanguard Total International Bond ETF | 25,882 | $1.3M | $1.24M | - | -$64,835.93 | -4.98% | -0.23% |
BRK-B Berkshire Hathaway Inc. | 1,115 | $510,477.84 | $570,367.1 | - | $59,889.26 | 11.73% | +0.365% |
BSV Vanguard Short-Term Bond ETF | 287,328 | $22.2M | $22.29M | - | $93,005.6 | 0.42% | -0.077% |
DFAC Dimensional U.S. Core Equity 2 ETF | 973,802 | $25.95M | $43.32M | - | $17.37M | 66.93% | +0.361% |
DFAX Dimensional World ex U.S. Core Equity 2 ETF | 1.6M | $36.72M | $58.29M | - | $21.57M | 58.73% | -0.219% |
DFSE Dimensional Emerging Markets Sustainability Core 1 ETF | 12,889 | $398,864.23 | $594,195.79 | - | $195,331.56 | 48.97% | +0.32% |
DFSI Dimensional International Sustainability Core 1 ETF | 39,093 | $1.19M | $1.8M | - | $604,621.59 | 50.75% | -0.606% |
DFSU Dimensional US Sustainability Core 1 ETF | 38,980 | $1.11M | $1.84M | - | $724,143.07 | 65.03% | +0.671% |